The Oncology Institute of Hope and Innovation is a clinical research site located in Glendale, California, United States 91204.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
The Oncology Institute of Hope and Innovation has participated in 10 clinical trials with 4 currently active.
Therapeutic areas: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer.
Sponsors: Pfizer, Daiichi Sankyo, Nuvation Bio Inc..
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Oncology Institute of Hope and Innovation has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Oncology Institute of Hope and Innovation has 10 clinical trials on record, with 4 currently active. Their work covers HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer.
Yes — The Oncology Institute of Hope and Innovation holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.